A Policy Stalemate with a Human Cost: How Refurbished Medical Equipment Can Redefine Healthcare Access

Refurbished medical devices, certified to meet international safety and performance standards, offer a credible solution. At 30 to 70% lower cost than new equipment, they allow smaller hospitals to deploy…

Continue ReadingA Policy Stalemate with a Human Cost: How Refurbished Medical Equipment Can Redefine Healthcare Access

India’s biotech sector grows from $10 billion to over $195 billion in a decade: Jitendra Singh

Speaking at the 14th Foundation Day of the Biotechnology Industry Research Assistance Council (BIRAC), Singh attributed the growth to an enabling policy environment, strong public-private collaboration, and sustained government support…

Continue ReadingIndia’s biotech sector grows from $10 billion to over $195 billion in a decade: Jitendra Singh